Clinical Trials Browser

Phase 2 × Lung Neoplasms × laromustine × Clear all

NCT00282022 2013-11-06

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

Phase 2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma